- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The licensed producer confirmed it was acquiring Starseed in an all-stock deal valued at C$78 million set to close in December.
Shares of WeedMD (TSXV:WMD,OTCQX:WDDMF) jumped in the past few days following the dual announcement of an acquisition and financing deal.
Since the market close on Friday (November 29), WeedMD has risen 6.5 percent, and prices sit at C$0.99 as of 1:53 p.m. EST on Tuesday (December 3).
The volatility following the announcement caused the company’s CEO Keith Merker to write an open letter to investors, sent on Monday (December 2), addressing some of the headwinds the firm is facing that led to its acquisition of Starseed Holdings and an additional financing deal with the Labourers’ Pension Fund of Central and Eastern Canada (LPF).
“Capital has become scarce and expensive, and the adult-use market has been slower to ramp and at thinner margins for licensed producers than many originally anticipated,” Merker told investors. “These market pressures have forced us, like many others, to reevaluate our business.”
On Friday, the licensed producer (LP) confirmed it was acquiring the Toronto-based cannabis company Starseed in an all-stock deal valued at C$78 million, which is set to close later in December.
As a part of the transaction, LPF, Starseed’s largest backer, will make a concurrent C$25 million equity investment into WeedMD.
The cash infusion comes at a critical time in an industry marred by an increased difficulty to put together financing deals amid market volatility and adjustments in valuations.
Merker added that while the firm had succeeded in making its cannabis production as cost-effective as possible, it had struggled to lock its own high-margin distribution channels and establish a strong balance sheet.
That’s where Starseed comes in, according to Merker.
WeedMD said this new deal between itself and Starseed will leverage its low-cost production against Starseed’s sales channels to boost the revenue generation while saving up to C$10 million per year by the end of 2020.
Thanks to LPF’s investment, WeedMD said its pro forma cash balance now sits at approximately C$56 million. The deal gives WeedMD shareholders 55 percent of the new company, while Starseed shareholders, including LPF, will own 45 percent.
Starseed boasts a medical-focused approach to the marijuana industry. Through a partnership with Canada’s largest construction union, the Laborers’ International Union of North America (LiUNA), Starseed offers medical cannabis as a fully covered benefit to LiUNA’s more than 100,000 members and retirees.
“Starseed brings a critical part of this business equation that has been difficult for the market to find: consistent, sticky distribution channels with direct access to fully covered and insured patients,” said Merker during an earnings call on Friday.
WeedMD follows acquisition news with quarterly results
Friday proved to be a packed day for WeedMD as the company also released its results for Q3 2019.
Net revenue came in at C$6.7 million, down from the nearly C$8 million generated during the previous quarter. There was also a drop in the gross profit before changes in fair value to C$1.9 million in Q3 from C$3.7 million in Q2.
The firm’s first outdoor harvest cultivation yield brought in eight tons of dried cannabis at a cost-to-harvest of C$0.16 per gram.
The yield now comes under the company’s anticipated weight, but as Merker explained, his firm is still finding its way through the world of outdoor harvesting.
“This was our first outdoor season and opportunity to figure out what works best — everything from proper nutrients, watering requirements, irrigation needs, air flow, etc.,” the executive said.
During the call, Merker assured investors and analysts that the yield was of high quality. The executive said of the over 35 strains originally planted, a majority of the strains contained over 20 percent of tetrahydrocannabinol (THC).
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.